title: Significance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccine.
abstract: Because large numbers of volunteer blood donors may be disqualified for "false-positive" results on tests for antibody to hepatitis B core antigen (anti-HBc), a more specific definition of anti-HBc enzyme immunoassay (EIA)-reactive was evaluated, including only those donor samples that were "strongly" reactive (sample-to-cutoff absorbance ratio, < 0.45). Results using this definition and other anti-HBc test methods were compared to the serologic response (antibody to hepatitis B surface antigen [anti-HBsAg]) to hepatitis B vaccination. Fifty-eight volunteer blood donors who had previously been deferred as donors, because of reactive anti-HBc tests (all other blood screening tests were negative, including those for HBsAg and anti-HBsAg) on two occasions, were vaccinated for hepatitis B. It was assumed that an anamnestic response to vaccine indicated past infection with hepatitis B, while a primary response to vaccine indicated lack of past infection. One (2%) of 43 donors with a historically "weak" anti-HBc (reactive absorbance ratio, > or = 0.45) had an anamnestic response to vaccine, compared to 8 (53%) of 15 with historically "strong" anti-HBc (reactive absorbance ratio, < 0.45) (p < 0.005). Anti-HBc testing using the microparticle EIA method also correlated well with hepatitis B vaccination results. The use of a narrower definition of "reactive" for anti-HBc EIA testing yielded much more specific, but slightly less sensitive, results.
authors: Sacramento Medical Foundation Blood Center, California.
authors: S K
authors: SK
authors: Aoki
authors: D
authors: D
authors: Finegold
authors: I K
authors: IK
authors: Kuramoto
authors: C
authors: C
authors: Douville
authors: C
authors: C
authors: Richards
authors: R
authors: R
authors: Randell
authors: L
authors: L
authors: Fernando
authors: P V
authors: PV
authors: Holland
authors: J B
authors: JB
authors: Zeldis
mesh_terms: D001782:Blood Donors; D005189:False Positive Reactions; D006509:Hepatitis B / Q000175:diagnosis / Q000517:prevention & control; D006510:Hepatitis B Antibodies / Q000097:blood* / Q000276:immunology; D006512:Hepatitis B Core Antigens / Q000276:immunology*; D017325:Hepatitis B Vaccines / Q000097:blood* / Q000276:immunology / Q000627:therapeutic use; D006801:Humans; D007124:Immunoenzyme Techniques; D007156:Immunologic Memory; D013997:Time Factors; D014611:Vaccination
chemical_list: D006510:Hepatitis B Antibodies; D006512:Hepatitis B Core Antigens; D017325:Hepatitis B Vaccines